[go: up one dir, main page]

NO972529D0 - Forbindelse for inhibering av mavesyresekresjon - Google Patents

Forbindelse for inhibering av mavesyresekresjon

Info

Publication number
NO972529D0
NO972529D0 NO972529A NO972529A NO972529D0 NO 972529 D0 NO972529 D0 NO 972529D0 NO 972529 A NO972529 A NO 972529A NO 972529 A NO972529 A NO 972529A NO 972529 D0 NO972529 D0 NO 972529D0
Authority
NO
Norway
Prior art keywords
acid secretion
stomach acid
inhibition compound
secretion inhibition
compound
Prior art date
Application number
NO972529A
Other languages
English (en)
Other versions
NO972529L (no
Inventor
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO972529L publication Critical patent/NO972529L/no
Publication of NO972529D0 publication Critical patent/NO972529D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO972529A 1994-12-08 1997-06-03 Forbindelse for inhibering av mavesyresekresjon NO972529D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/351,852 US5556863A (en) 1993-06-11 1994-12-08 Compound for gastric acid secretion inhibition
PCT/SE1995/001369 WO1996017830A1 (en) 1994-12-08 1995-11-17 Compounds for inhibition of gastric acid secretion

Publications (2)

Publication Number Publication Date
NO972529L NO972529L (no) 1997-06-03
NO972529D0 true NO972529D0 (no) 1997-06-03

Family

ID=23382690

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972529A NO972529D0 (no) 1994-12-08 1997-06-03 Forbindelse for inhibering av mavesyresekresjon

Country Status (20)

Country Link
US (1) US5556863A (no)
EP (1) EP0796249A1 (no)
JP (1) JPH10510259A (no)
CN (1) CN1169142A (no)
AR (1) AR001996A1 (no)
BR (1) BR9509888A (no)
CA (1) CA2205896A1 (no)
EE (1) EE9700131A (no)
FI (1) FI972410A0 (no)
HU (1) HUT77949A (no)
IL (1) IL116285A0 (no)
IS (1) IS4485A (no)
MX (1) MX9704136A (no)
NO (1) NO972529D0 (no)
NZ (1) NZ297566A (no)
PL (1) PL320754A1 (no)
SK (1) SK63797A3 (no)
TR (1) TR199501536A2 (no)
WO (1) WO1996017830A1 (no)
ZA (1) ZA9510066B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042702A (en) * 1973-08-16 1977-08-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogen pyrazole derivatives, a method for producing these halogen pyrazole derivatives, medicaments containing and methods of using them
LU69428A1 (no) * 1974-02-20 1975-12-09
US4120972A (en) * 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Imidazolylmethylthio-ethyl isothiourea compounds
ATA210876A (de) * 1975-03-25 1979-01-15 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von neuen nidrofuryl- pyrazolderivaten
AT364354B (de) * 1976-10-14 1981-10-12 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von neuen pyrazol-1yl-phenylessigsaeuren, deren salzen und optischen isomeren
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4243678A (en) * 1977-12-30 1981-01-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylhydrocarbylaminoalkanoic acids, compositions and uses
YU118379A (en) * 1978-05-24 1983-02-28 Byk Gulden Lomberg Chemischefa Process for preparing phenylaminothiophene acetic acid
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
EP0064775A1 (de) * 1979-08-03 1982-11-17 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte Tetraazatricyclen, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0024638A1 (en) * 1979-08-30 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituted quinolinone-alkanecarboxylic acids, their preparation, and medicaments containing them
EP0025192B1 (de) * 1979-09-07 1983-05-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
ES8202780A1 (es) * 1979-10-31 1982-03-01 Byk Gulden Lomberg Chem Fab Procedimiento para la preparacion de acidos oxocarboxilicos sustituidos
US4381301A (en) * 1980-05-07 1983-04-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments
US4337267A (en) * 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
WO1982000822A1 (en) * 1980-08-29 1982-03-18 Eistetter K Substituted oxiranecarboxylic acids,their preparation and their use as medicaments
EP0057428B1 (de) * 1981-02-02 1985-04-10 Byk Gulden Lomberg Chemische Fabrik GmbH Tricyclische Pyrrole, Verfahren zu ihrer Herstellung, ihre Anwendung sowie sie enthaltende Arzneimittel
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
DK585485A (da) * 1984-12-18 1986-08-08 Utsuka Pharm Co Ltd Tetrahydroquinolinderivat, imidazopyridinderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat med mindst en saadan forbindelse
US5250527A (en) * 1985-10-24 1993-10-05 Smithkline & French Laboratories Limited Pyridyl containing benzimidazoles, compositions and use
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8717644D0 (en) * 1987-07-24 1987-09-03 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5049567A (en) * 1988-02-25 1991-09-17 Smithkline Beckman Intercredit B.V. Substituted 4-aminoquinazoline derivatives and method of use
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
GB8908229D0 (en) * 1989-04-12 1989-05-24 Smithkline Beckman Intercredit Compounds
GB8910722D0 (en) * 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
DK0480052T3 (da) * 1990-03-28 1998-05-11 Otsuka Pharma Co Ltd Quinolinderivat, antiulcus-lægemiddel indeholdende derivatet og fremstilling af derivatet
EP0569396A1 (en) * 1991-01-29 1993-11-18 Smithkline Beecham Intercredit B.V. Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru

Also Published As

Publication number Publication date
AU697006B2 (en) 1998-09-24
NO972529L (no) 1997-06-03
TR199501536A2 (tr) 1996-07-21
MX9704136A (es) 1998-02-28
EE9700131A (et) 1997-12-15
CA2205896A1 (en) 1996-06-13
IL116285A0 (en) 1996-03-31
CN1169142A (zh) 1997-12-31
JPH10510259A (ja) 1998-10-06
PL320754A1 (en) 1997-10-27
AU4274896A (en) 1996-06-26
BR9509888A (pt) 1997-10-21
FI972410L (fi) 1997-06-06
FI972410A7 (fi) 1997-06-06
FI972410A0 (fi) 1997-06-06
EP0796249A1 (en) 1997-09-24
ZA9510066B (en) 1996-06-10
WO1996017830A1 (en) 1996-06-13
US5556863A (en) 1996-09-17
SK63797A3 (en) 1998-07-08
IS4485A (is) 1997-05-22
HUT77949A (hu) 1998-12-28
AR001996A1 (es) 1998-01-07
NZ297566A (en) 1998-12-23

Similar Documents

Publication Publication Date Title
NO994078D0 (no) Forbindelser for inhibisjon av mavesyresekresjon
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
DK0770169T3 (da) Hydratinhibering
DK0944386T3 (da) Sulfonsyre- eller sulfonylamino-N-(heteroaralkyl)-azaheterocyclylamid-forbindelser
ID17723A (id) Senyawa untuk pengobatan
NO991561D0 (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
FI940511A0 (fi) Menetelmä ferrisulfaatin valmistamiseksi
GB2355657B (en) Inhibitors Of Gastric Acid Secretion
NO961783D0 (no) 5-arylisoxazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
NO972529D0 (no) Forbindelse for inhibering av mavesyresekresjon
FI922125L (fi) Mikrobidogiskt foerfarande foer framstaellning av 5-hydroxipyrazinkarboxylsyra
NO974876D0 (no) Fremgangsmåte for fremstilling av en dihydroksyaminoforbindelse
DE69311355D1 (de) Persäure-verbindungen
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
HK1002151A (en) Compounds for inhibition of gastric acid secretion
NO994261L (no) Fremgangsmåte for fremstilling av trovafloxacinsyresalter
NO991098L (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
FI911748A7 (fi) Fenyylisulfonyylialkanihappoyhdisteitä
FI913141L (fi) Sulfonering av ligniner med rykande svavelsyra